Furthermore, IL-17 was shown to promote angiogenesis and colorectal tumorigenesis in human colorectal cancer cells and ablation of IL-17A significantly reduced tumor development in mice [99–101]. The gene discussed is IL17A; the disease is colorectal cancer.